[go: up one dir, main page]

SI3490988T1 - Nova spojina in postopek - Google Patents

Nova spojina in postopek

Info

Publication number
SI3490988T1
SI3490988T1 SI201730098T SI201730098T SI3490988T1 SI 3490988 T1 SI3490988 T1 SI 3490988T1 SI 201730098 T SI201730098 T SI 201730098T SI 201730098 T SI201730098 T SI 201730098T SI 3490988 T1 SI3490988 T1 SI 3490988T1
Authority
SI
Slovenia
Prior art keywords
new compound
compound
new
Prior art date
Application number
SI201730098T
Other languages
English (en)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of SI3490988T1 publication Critical patent/SI3490988T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI201730098T 2016-07-28 2017-07-27 Nova spojina in postopek SI3490988T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process
EP17748880.6A EP3490988B1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
SI3490988T1 true SI3490988T1 (sl) 2019-11-29

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201730098T SI3490988T1 (sl) 2016-07-28 2017-07-27 Nova spojina in postopek

Country Status (19)

Country Link
US (1) US10710998B2 (sl)
EP (1) EP3490988B1 (sl)
JP (1) JP6985367B2 (sl)
KR (1) KR102396059B1 (sl)
CN (1) CN109641891B (sl)
CY (1) CY1122138T1 (sl)
DK (1) DK3490988T3 (sl)
ES (1) ES2751948T3 (sl)
GB (1) GB201613054D0 (sl)
HR (1) HRP20192109T1 (sl)
HU (1) HUE046509T2 (sl)
LT (1) LT3490988T (sl)
PL (1) PL3490988T3 (sl)
PT (1) PT3490988T (sl)
RS (1) RS59566B1 (sl)
SI (1) SI3490988T1 (sl)
SM (1) SMT201900582T1 (sl)
TW (1) TWI739871B (sl)
WO (1) WO2018020249A1 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3231444T3 (da) 2014-05-12 2020-03-16 Verona Pharma Plc Ny behandling
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
JP7798770B2 (ja) * 2020-01-17 2026-01-14 ルピン・リミテッド クロマン化合物を調製するための方法、プロセスおよび中間体
CA3211820A1 (en) 2021-04-29 2022-11-03 Zhiya LI Isoquinolone compound and use thereof
JP2024545189A (ja) * 2021-12-14 2024-12-05 シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド 三環式縮合複素環系pde3/4二重阻害剤及びその用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
AU2024309346A1 (en) 2023-06-26 2026-01-08 Verona Pharma Plc Particulate composition comprising ensifentrine
WO2025052119A1 (en) 2023-09-06 2025-03-13 Verona Pharma Plc Ensifentrine for use in treating chronic obstructive pulmonary disease (copd)
WO2025168708A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
US20250249007A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ZW6284A1 (en) 1983-05-05 1985-10-30 Hoffmann La Roche Novel pyrimidone derivatives
CA2368413C (en) 1999-03-31 2008-07-29 Vernalis Limited Derivatives of pyrimido[6,1-a]isoquinolin-4-one
TWI516488B (zh) 2010-08-09 2016-01-11 維羅納製藥Plc公司 嘧啶并[6,1-a]異喹啉-4-酮化合物之結晶型
US9700558B2 (en) 2013-03-15 2017-07-11 Verona Pharma Plc Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
DK3231444T3 (da) 2014-05-12 2020-03-16 Verona Pharma Plc Ny behandling
CA2959943C (en) 2014-09-15 2022-08-16 Verona Pharma Plc Liquid inhalation formulation comprising rpl554
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
EP3490988B1 (en) 2019-08-28
TWI739871B (zh) 2021-09-21
KR20190034231A (ko) 2019-04-01
EP3490988A1 (en) 2019-06-05
CN109641891A (zh) 2019-04-16
JP6985367B2 (ja) 2021-12-22
CN109641891B (zh) 2021-05-04
SMT201900582T1 (it) 2019-11-13
US20190330206A1 (en) 2019-10-31
US10710998B2 (en) 2020-07-14
DK3490988T3 (da) 2019-10-28
TW201806951A (zh) 2018-03-01
CY1122138T1 (el) 2020-11-25
WO2018020249A1 (en) 2018-02-01
HRP20192109T1 (hr) 2020-02-21
RS59566B1 (sr) 2019-12-31
HUE046509T2 (hu) 2020-03-30
ES2751948T3 (es) 2020-04-02
JP2019527228A (ja) 2019-09-26
PL3490988T3 (pl) 2020-02-28
PT3490988T (pt) 2019-10-28
GB201613054D0 (en) 2016-09-14
KR102396059B1 (ko) 2022-05-10
LT3490988T (lt) 2019-10-10

Similar Documents

Publication Publication Date Title
GB201609546D0 (en) Process
PT3490988T (pt) Novo composto e processo
GB201615268D0 (en) Process
GB201609873D0 (en) Process
GB201615270D0 (en) Process
GB201612248D0 (en) New process
GB201600290D0 (en) Process
GB201615762D0 (en) Process
GB201602584D0 (en) Process
GB201608779D0 (en) Methods and compounds
GB201617500D0 (en) Process
GB201503776D0 (en) Compound and method
GB201602646D0 (en) Process
GB201600456D0 (en) Process
GB201600287D0 (en) Process
GB201620667D0 (en) Process
GB201608776D0 (en) Methods and compounds
GB201610852D0 (en) Process
GB201613014D0 (en) Process
GB201701507D0 (en) Process
GB201620525D0 (en) Process
GB201501593D0 (en) New compounds and processes
GB201602576D0 (en) Process
GB201601514D0 (en) New processes and compounds
GB201609545D0 (en) Process